Please login to the form below

Not currently logged in
Email:
Password:

life sciences

This page shows the latest life sciences news and features for those working in and with pharma, biotech and healthcare.

Life science companies can’t keep up with technology competitors

Life science companies can’t keep up with technology competitors

Life Sciences 4.0: Securing value through data-driven platforms details that more than 75% of life science organisations currently included in the Fortune 500 could be pushed out of this ... Spence added: “To seize the upside of disruption in this

Latest news

  • Bayer looks to leverage AI across the pharma value chain Bayer looks to leverage AI across the pharma value chain

    The company is, he said, “all over this”, having already collaborated with the likes of Verily, the life sciences unit at Google parent company Alphabet, and IBM’s Watson and Deep

  • IQVIA partners with Box IQVIA partners with Box

    IQVIA partners with Box. Will work on managing content for the life science industry. ... Riju Khetarpal, managing director, global life sciences at Box, said: “We’re excited to welcome an innovative company such as IQVIA into the Box technology

  • Hume Brophy launches new life science division Hume Brophy launches new life science division

    Public and corporate affairs agency Hume Brophy has launched a new life sciences arm to its international healthcare business. ... Hume Brophy Life Sciences will provide a targeted approach to healthcare communications and further help their clients

  • Fujitsu begins two-year medical AI research project Fujitsu begins two-year medical AI research project

    Meanwhile, last year saw an uptick in life sciences interest in applying AI to drug research, with the likes of Scotland’s Exscientia scoring deals withand Sanofi, and Lundbeck signing up

  • Takeda gets FDA fast-track status for Zika vaccine Takeda gets FDA fast-track status for Zika vaccine

    Last year Inovio Pharma and GeneOne Life Sciences reported phase I data with their synthetic GLS-5700 DNA vaccine in the New England Journal of Medicine (NEJM), concluding that it was

More from news
Approximately 28 fully matching, plus 509 partially matching documents found.

Latest Intelligence

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    The Life Sciences Industrial Strategy published in the autumn echoes many of these sentiments. ... In particular, it outlines the need for industry to take on bold, far-sighted ambitions in the life science industry with the intention of creating

  • The Patient Safety Challenge The Patient Safety Challenge

    They were asked to focus on real-life medication-related harm scenarios presented to them, how these were handled and what they would have done in similar circumstances. ... are from Robert Gordon University’s School of Pharmacy and Life Sciences.

  • When is it time to rebrand? When is it time to rebrand?

    Share best practices both in and outside of the life sciences category.

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    The Life Sciences Industrial Strategy published in the autumn echoes many of these sentiments. ... In particular, it outlines the need for industry to take on bold, far-sighted ambitions in the life science industry with the intention of creating

  • A catalyst for change A catalyst for change

    This liability exists throughout the life cycle of the drugs. Under the MAH regime, a Chinese domestic applicant is a drug manufacturer or a drug research institution that is legally registered ... is managing partner of CMS Beijing and global co-head of

More from intelligence
Approximately 10 fully matching, plus 58 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 166 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics